Navigation Links
Breast implants not associated with cancer risk, study reports

Having breast implants is not associated with an increased risk of cancer overall, a new study reports in the April 19 issue of the Journal of the National Cancer Institute. Implants were associated with a decrease in breast cancer risk and an increased lung cancer risk, but these results likely reflect the lifestyles and smoking habits of the women in the study rather than an effect of the implants themselves, the authors conclude.

Past reports have examined the association between cosmetic breast implants and cancer risk, particularly breast cancer risk, but no consistent associations have been found. However, few studies have examined this association after more than 15 years.

Joseph K. McLaughlin, Ph.D., of the International Epidemiology Institute in Rockville, Md., and Vanderbilt-Ingram Cancer Center in Nashville, and colleagues examined the incidence of cancer in a nationwide cohort of 3486 Swedish women who underwent cosmetic surgery for breast implants between 1965 and 1993 and were followed until the end of 2002. Data was obtained from the Swedish Cancer Registry, which reports on cancer occurrence for the entire country. The average follow-up time was 18.4 years. The study is the longest follow-up study on cosmetic breast implants and risk of cancer incidence to date.

The authors identified 180 cancers in women with breast implants, fewer than the 193.1 predicted to occur in this population. Cosmetic implants were not associated with an increased risk of cancer overall. Women with implants had an increased incidence of lung cancer (20 cases observed, 9.1 cases expected) and a decreased incidence of breast cancer (53 cases observed, 71.9 cases expected) compared with the general population.

The authors suggest the higher incidence of lung cancer may be due to the high rates of smoking in Swedish women with cosmetic breast implants. Lower breast cancer incidence could be explained by the lower body mass index, higher number of births, and younger age at first childbirth observed in the group of women who had undergone breast implantation.

The authors write, "After an average follow-up of 18 years, and a maximum follow-up of 37 years, we found that women who have undergone breast implantation have a reduced risk for breast cancer, most likely due to differences in lifestyle or reproductive characteristics. We also found no increased risk for brain cancer or for lymphoma, sarcoma, or multiple myeloma," cancers of concern because of earlier suggestive observations.


'"/>

Source:Journal of the National Cancer Institute


Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
3. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
4. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
5. New Breast Cancer Test Could Save Lives
6. Breast Cancer May Be Uniquely Sensitive To Inhibitors Of PI3K Pathway
7. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
8. Nanoparticle Breast Cancer Drug Approved by FDA
9. Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer
10. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
11. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology: